Move compliant content forward without slowing it down

Compliance complexity meets disconnected systems

Pharma content approval workflows do not fail because of a lack of rigor. They fail because the systems managing them were not built for the realities of MLR review.

Reviews are modeled as linear queues with a single sign-off, not as parallel review with a defined resolution path for when reviewers disagree. Electronic signatures are bolted on as a separate step after the decision rather than embedded into the decision itself. Audit trails are reconstructed after the fact from email, comments, and version metadata rather than captured live. Internal medical commentary leaks to external agencies because there is no native way to control which audience sees which feedback. Localized variants drift from approved masters because comparison is manual. Sensitive communications about patients or trial data move through general project chat instead of staying scoped to the people authorized to see them.

Add regulatory variation across regions (FDA, EMA, PMDA, MHRA, ANVISA, NMPA, and more) and the asset and approval volume multiplies. The burden grows. Timelines extend. Compliance risk increases even as effort increases.

Compliance controls and decision-driven MLR workflow, in a single platform

Aproove brings the entire regulated content lifecycle into one structured system, with compliance controls embedded into every step and a workflow engine designed for the realities of multi-stakeholder MLR review.

Compliance built into the workflow

Electronic signatures aligned to 21 CFR Part 11. Configure any task decision to require a re-authenticated email and password confirmation at the moment the decision is made. Add two-factor authentication via PIN code on top, where the regulatory bar requires it. Identity enforcement prevents tasks from being forwarded to a different user, so the signed-by user is verifiably the user who made the decision. Signatures are bound to the specific decision, the specific user, and the specific timestamp.

Audit trail captured live, not reconstructed. Every user action and every system action is logged with timestamps in the project history, exportable as CSV. Project Chat preserves the originally posted content even after edits, by design, so an audit trail of what was originally said is always available. The Export PDF function combines the proof, every annotation, every comment, and the workflow history into a single submission-ready packet. Project history persists in the admin even after a project is deleted.

Annotation Flow Management for separated audiences. Aproove's Annotation Flow Management (AFM) gives granular control over which user groups see which notes within a single review step. Medical reviewers' clinical commentary stays invisible to external agencies until elevated by a manager. Internal regulatory feedback can be hidden from brand teams until ready. Group managers move notes up or down the hierarchy as the review matures. AFM is unique to Aproove and is built specifically for the layered-audience reality of regulated review.

Sensitive communications stay scoped. Private Task Chat provides a chat scope that does not feed into the project chat room, designed for communications involving billing, financial information, or HIPAA-protected health information. Combined with email whitelisting and identity enforcement, sensitive content stays inside the audience that should see it.

Platform-level security posture. Aproove is ISO 27001 certified, SOC 2 attested, and operates as a GDPR data processor, with HIPAA-compliant infrastructure, tenant-isolated hosting, encryption at rest and in transit, and role-based access enforcement at every level of the platform.

Deployment that meets your data residency and validation requirements. Aproove can be deployed as managed cloud, on-premise inside your data center, or self-hosted in your own cloud tenant. Pharma teams that require validated environments, regional data residency (EU-only, US-only, or country-specific), customer-managed encryption keys, or air-gapped operation for sensitive trial and regulatory content can choose the deployment model that fits their governance, without giving up the platform capabilities. The same workflow engine, the same e-signatures, the same audit trail, on the infrastructure your security and compliance teams approve.

Decision-driven workflow built for MLR

Decisions route the work, not the other way around. Each task in an Aproove workflow has decision buttons that determine what happens next. "Medical approved" sends the work forward, "Legal needs revision" returns it to the writer, "Substantive change" branches to full MLR, "Minor change" routes to the expedited path, "Escalate to compliance" pulls in a separate reviewer chain. Workflows can be linear, parallel, branching, conditional, or circular. The same decision can also fire one of more than 40 automated actions: notify a third-party system (DAM, MIS, regulatory submission tool), generate a compliance report, kick off a localization project, update metadata, alert the next reviewer in the chain.

Parallel MLR without ambiguity. Medical, legal, regulatory, brand, and external review can all run simultaneously on the same asset. Aproove tracks each reviewer's decision separately. When decisions conflict, Aproove routes a conflict task to a designated conflict manager, who can override, extend the deadline, take the decision themselves, or send the work back for reconciliation. The same mechanism handles missed deadlines. Conflict managers can be assigned statically or dynamically based on project metadata, so the right escalation path resolves the right asset (for instance, the therapeutic area medical lead for clinical conflicts, the regional regulatory lead for jurisdictional ones).

Master and local comparison built in. Compare any localized variant against the approved master template using Compare View, with synced zoom and pan, pixel-level Highlight Differences, and Text Extraction that color-codes additions and deletions. Reviewers can see at a glance whether a German, Japanese, or Brazilian variant has introduced unauthorized claim changes, altered fair balance, or shifted ISI placement. Naming conventions can automate the master-to-variant matching, so the comparison is set up once and runs every cycle.

Localized for global teams. Tasks, decision buttons, invitations, and notification templates can all be localized, so the German regulatory reviewer answers their workflow in German while the global brand team sees the same workflow in English. Localized labels do not change the underlying decision keys, so reporting and auditing stay consistent across regions.

Built for exceptions and external collaboration. Project managers send Instant Share tasks ad hoc to bring in legal, compliance, or an external KOL without modifying the running workflow. Team tasks let any qualified group member claim a task from their to-do list. Webhook-driven external project creation, protected by reCAPTCHA and optional 2FA email verification, lets external agencies and KOLs participate compliantly without licensed accounts.

Optional AI assistance under full governance. Aproove AI Agents operate inside the platform's audit and permission boundary. They are assistive, not autonomous, with human-in-the-loop decision authority, customer-controlled OpenAI keys (so enterprises can use their own OpenAI agreement and governance), no external publishing capability, configurable enable/disable per project or asset type, and a full audit trail of every AI-assisted action. Customer data is not used to train shared models. Teams that want AI to help with reference checking, fair-balance review, or claim consistency can adopt it without losing the audit posture.

From fragmented approvals to controlled compliance

With Aproove, compliance is no longer a bottleneck. It becomes part of how work flows.

Sequential reviews become parallel collaboration with a defined resolution path. Feedback is centralized instead of scattered, and visible to the audiences that should see it. Version control becomes automated instead of manual. Electronic signatures fire at the moment of decision rather than as a follow-up step. Master and local comparison runs as part of review, not as a separate manual check. Audit packets export at the end of the project rather than being assembled from screenshots and email forwards.

Instead of managing complexity, teams operate within a system that organizes it.

The result is fewer delays, fewer errors, and a process that scales with regulatory demands for strong GxP compliance.

Accuracy, speed, and traceability are inseparable

In pharma, the cost of error is high, but so is the cost of delay. Bringing therapies and information to market faster has real-world impact, but only if compliance is maintained.

A missed fair-balance statement on an HCP piece can trigger an FDA letter. An unauthorized claim in a localized variant can mean withdrawal of the campaign in that market. A signature gap can fail a Part 11 audit. An undocumented MLR comment that influenced a final decision but never made it into the record can compromise a submission. Each of these can be caught in advance with the right system, and each of them can quietly slip through with the wrong one.

Aproove enables both speed and traceability by embedding compliance into every step of the workflow. Every decision is signed and traceable, every approval is documented at the moment it is made, every variant is checked against its approved master, and every asset reaches publication with the audit trail already complete.

The result is a system that supports innovation without compromising safety or regulatory integrity.